Perioperative complications in patients with drug-eluting stents: A three-year audit at Geelong Hospital

Anaesthesia and Intensive Care

Volumn 35, Issue 6, 2007, Pages 939-944

  Conroy, M ^a   Bolsin, S N C ^a   Black, S A ^a   Orford, N ^a  

^a GEELONG HOSPITAL   (Australia)

Author keywords

Complications; Drug eluting stent; Myocardial infarction; Perioperative clopidogrel; Perioperative complications

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; HEPARIN; PACLITAXEL; TIROFIBAN; WARFARIN;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; RISK ASSESSMENT; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT OUTCOME;

EID: 37049036365     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0703500613     Document Type: Article

References (26)

1. Gershlick AH. Is there any place for oral anti-restenotic treatment in the era of drug eluting stents? Heart 2005; 91:1377-1379.
2. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007; 49:2145-2150.
3. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br J Anaesth 2006; 96:686-693.
4. Howard-Alpe GM, de Bono J, Hudsmith L, Orr WP, Foex P, Sear JW. Coronary artery stents and non-cardiac surgery. Br J Anaesth 2007; 98:560-574.
5. Broad L, Lee T, Conroy M, Bolsin S, Orford N, Black A et al. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 2007; 98:19-22.
6. Yan BP, Ajani AE, Duffy SJ, New G, Horrigan M, Szto G et al. Use of drug-eluting stents in Victorian public hospitals. Med J Aust 2006; 185:363-367.
7. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45:2088-2092.
8. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48:193-202.
9. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006; 47:2108-2111.
10. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130.
11. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113:1108-1113.
12. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. J Am Coll Cardiol 2006; 47:2112-2115.
13. Wessely R, Schomig A, Kastrati A. Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. J Am Coll Cardiol 2006; 47:708-714.
14. Eisenberg MJ. Drug-eluting stents: some bare facts. Lancet 2004; 364:1466-1467.
15. McFadden EP, Stabile E, Regar E, Cheneau E, Ong ATL, Kinnaird T et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364:1519-1521.
16. Patterson L, Hunter D, Mann A. Appropriate waiting time for noncardiac surgery following coronary stent insertion: views of Canadian anesthesiologists. Can J Anesth 2005; 52:440-441.
17. Nasser M, Kapelovich M, Markiewicz W. Late thrombosis of Sirolumus-Eluting Stents Following Noncardiac Surgery. Catheter Cardiovasc Interventions 2005; 65:516-519.
18. Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001; 86:262-264.
19. Lee CH, Lim J, Low A, Tan HC, Lim YT. Late angiographic stent thrombosis of polymer based paclitaxel eluting stent. Heart 2006; 92:551-553.
20. Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288:2411-2420.
21. Cuthill JA, Young S, Greer IA, Oldroyd K. Anaesthetic considerations in a parturient with critical coronary artery disease and a drug-eluting stent presenting for Caesarian section. Int J Obstet Anesth 2005; 14:167-171.
22. Dalal AR, D'Souza S, Shulman M. Brief review: Coronary drug-eluting stents and anesthesia. Can J Anesth 2006; 53:1230-1243.
23. Bolsin S, Broad L, Conroy M, Black S, Orford N, Birdsey G. Successful management of patients with a drug-eluting coronary stent presenting for elective surgery. Br J Anaesth 2007; 98:841-842.
24. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004; 110:1202-1208.
25. Hongo RH, Ley J, Dick SE, Yee RR. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002; 40:231-237.
26. Chu MW, Wilson SR, Novick RJ, Stitt LW, Quantz MA. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004; 78:1536-1541.